Literature DB >> 9756161

New use for an old drug: amantadine benefits levodopa-induced dyskinesia.

A H Rajput, A Rajput, A E Lang, R Kumar, R J Uitti, N Galvez-Jimenez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9756161     DOI： 10.1002/mds.870130520

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  4 in total

Review 1.  Patterns and Determinants of Prescribing for Parkinson's Disease: A Systematic Literature Review.

Authors:  Khalid Orayj; Emma Lane
Journal:  Parkinsons Dis       Date:  2019-11-03

2.  Intravenous amantadine for freezing of gait resistant to dopaminergic therapy: a randomized, double-blind, placebo-controlled, cross-over clinical trial.

Authors:  Young Eun Kim; Ji Young Yun; Hui June Yang; Han-Joon Kim; Namyi Gu; Seo Hyun Yoon; Joo-Youn Cho; Beom S Jeon
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

3.  Amantadine in the treatment of pathological gambling: a case report.

Authors:  Mauro Pettorruso; Giovanni Martinotti; Marco Di Nicola; Marco Onofrj; Massimo Di Giannantonio; Gianluigi Conte; Luigi Janiri
Journal:  Front Psychiatry       Date:  2012-11-27       Impact factor: 4.157

Review 4.  Amantadine for dyskinesia in Parkinson's disease.

Authors:  N J Crosby; K H O Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.